Gram-negative Bacteremia
📧 Sign up to get email alerts when something new happens for Gram-negative Bacteremia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial [NA]
Completed clinical trial evaluating fast antibiotic susceptibility testing for Gram-negative bacteremia; results posted.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Early Oral Switch for Uncomplicated Gram-negative Bacteraemia [Phase 4]
Phase 4 clinical trial examining an early oral switch strategy for uncomplicated gram-negative bacteremia is currently recruiting. The study…
-
CLINICAL_TRIALS withdrawal · 2026-03-12Clinical Trial Update: Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation [Phase 2]
Phase 2 clinical trial on decolonization of antimicrobial-resistant organisms after microbiome perturbation was withdrawn.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial [NA]
Johns Hopkins University is sponsoring a trial evaluating an oral antibiotic therapy for Gram-negative bacteremia, and the study is currentl…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Platform Trial for Gram Negative Bloodstream Infections [NA]
A platform clinical trial investigating treatments for Gram-negative bloodstream infections is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU [NA]
The update summarizes a completed study evaluating whether rapid diagnostic tools BacT/Alert VIRTUO, BioFire BCID2, and REVEAL improve antib…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings [NA]
This clinical trial update from Assistance Publique - Hôpitaux de Paris investigates whether real-time MIC reporting within six hours influe…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial [NA]
A completed Duke University–sponsored trial evaluating rapid antibiotic susceptibility testing for Gram-negative bacteremia and bloodstream …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: BALANCE+ Vanguard Phase [NA]
The BALANCE+ Vanguard Phase study sponsored by Sunnybrook Health Sciences Centre has completed for Gram-negative bacteremia.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia [Phase 4]
Phase 4 trial update on shortening antibiotic treatment to 5 days for Gram-negative bacteremia and urinary tract infection due to bacterial …
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia [NA]
Clinical trial update on rapid identification and phenotypic susceptibility testing for Gram-negative bacteremia; study completed with poste…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Gram Negative Bacteremia, Risk Factors for Failure of Therapy
This completed clinical trial evaluated risk factors associated with treatment failure in Gram-negative bacteremia.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Gram-negative Bacteremia in HSCT Recipients
This document reports a completed clinical trial update studying Gram-negative bacteremia in hematopoietic stem cell transplant recipients (…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Clinical Outcomes and Cost of Gram Negative Bacteremia
A completed clinical trial report focusing on clinical outcomes and the costs associated with Gram-negative bacteremia.